New Computer Model Sets New Precedent in Drug Discovery
November 19, 2014
(Phys.org) – Merging expertise from computer science and synthetic drug design, the new model reveals that the drug efficacy of fusion-protein therapies depends on the geometric characteristics of a drug’s molecular components. Use of the model could potentially replace the need to physically make and test new biologic drug designs, cutting down timelines and costs associated with drug development.